Rockefeller Capital Management’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Other funds holding TENX
Rockefeller Capital Management's TENX Position: Q3 2026 in Review
Rockefeller Capital Management held its Tenax Therapeutics (TENX) position steady in Q3 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4860.
Rockefeller Capital Management first reported a position in TENX in Q3 2025 and has held it in 5 quarters since. The position peaked at $40K in Q1 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.
- Rockefeller Capital Management held 1 share of Tenax Therapeutics worth $2 as of Q3 2026.
- Rockefeller Capital Management left its Tenax Therapeutics share count unchanged in Q3 2026.
- Tenax Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4860 holding.
- Rockefeller Capital Management first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 5 quarters since.
- Rockefeller Capital Management's Tenax Therapeutics position peaked at $40K in Q1 2026.
- 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.